DIRS.INFO The most relevant business & tech news

☆ Morningstar: Buy these 10 cheap, high-quality stocks that pay a healthy dividend to help offset stock market losses and slowing economic growth
▼ + stars: | 2023-01-24 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +3 min

Dividend stocks may take center stage during rough economic conditions in 2023. Morningstar's Dave Sekera recently listed 10 cheap, high-quality dividend-paying stocks to buy now. As equity valuations slumped into an official bear market last year, high-quality dividend-paying stocks took center stage to rise above their more speculative peers. According to Morningstar chief US market strategist Dave Sekera, it's no coincidence that dividend stocks stole the show in 2022. 10 high-quality dividend payersIn the video, Sekera identified 10 high-quality stocks that are currently trading below their fair values, have high upside potential, and have a "relatively decent or healthy" dividend yield payout.

☆ Medical device stocks tend to beat the market, and analysts expect these names to see big gains
▼ + stars: | 2023-01-23 | by ( Bertha Coombs | ) www.cnbc.com time to read: +4 min

Medical device makers, like many manufacturers, have faced challenges over the last year from inflationary supply chain costs, staffing shortages and the strong dollar impacting sales overseas. However, since 2007 the device sector ETF has averaged a gain of 14% per year, 6 percentage points better than the broader market index over the same period. More than 60% of analysts rate the shares a buy, with a mean price target implying 34% upside. Nearly 90% of analysts rate the stock a buy, with mean price target of $53, implying more than 30% upside. BTIG analysts Marie Thibault and Ryan Zimmerman think that M & A could be another catalyst for the medical device sector in 2023, with robotic surgery players likely to be of particular interest.

☆ What diabetes is revealing about the benefits and risks of personal medicine connected to the internet
▼ + stars: | 2023-01-21 | by ( Ellen Sheng | ) www.cnbc.com time to read: +4 min

Devices such as insulin pumps, which go back decades, and continuous glucose monitors, which monitor blood sugar levels 24/7, are increasingly connected to smartphones via Bluetooth. Sleep apnea, Type 2 diabetes and remote health careIt's not just diabetes where the medical device market is offering patients new benefits from remote monitoring. The number of internet-connected medical devices grew during the pandemic, as lockdowns created a big push to treat people at home. Multiple forms of medical cybersecurity riskIndustry security experts categorize cybersecurity risks of medical devices into three buckets. Many medical devices such as insulin pumps require patients to create online accounts to download data to a computer or smartphone.

☆ Cramer's lightning round: I like Juniper Networks
▼ + stars: | 2023-01-20 | by ( Krystal Hur | ) www.cnbc.com time to read: 1 min

Loading chart...AT&T Inc : "It's not as bad as it used to be." Loading chart...Plug Power Inc : "[CEO] Andy Marsh has promised us profitably for a very long time. Loading chart...Juniper Networks Inc : "I like Juniper Networks. I think KAR is very, very good." Disclaimer: Cramer's Charitable Trust owns shares of Devon Energy.

☆ Most therapeutic areas back to pre-pandemic levels, says Medtronic CEO
▼ + stars: | 2023-01-10 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMost therapeutic areas back to pre-pandemic levels, says Medtronic CEOGeoffrey Martha, Medtronic CEO, joins 'TechCheck' to discuss future of the company and his outlook for 2023.

☆ Baxter International plans to spin off kidney care units
▼ + stars: | 2023-01-06 | by ( ) www.reuters.com time to read: +2 min

Jan 6 (Reuters) - Baxter International Inc (BAX.N) said on Friday it plans to spin off its kidney care units, becoming the latest medical device maker to slim down in the face of supply-chain challenges. The company plans to spin off its renal care and acute therapies units into a separate listed entity in the next 12-18 months. Dialysis operations, which are a part of Baxter's renal care unit, are a drag on the parent company's margins today, said Chief Financial Officer James Saccaro. For the nine months ended Sept. 30, the renal care unit reported sales of $2.77 billion, down from $2.87 billion the previous year. The acute therapies unit posted sales of $519 million, declining from $580 million a year ago.

☆ Jim Cramer's top 10 things to watch in the market Wednesday: Tech layoffs, bank double downgrade, opportunities in industrials
▼ + stars: | 2023-01-04 | by ( Jim Cramer | ) www.cnbc.com time to read: +4 min

Analysts lower their rating on the tech giant to neutral from buy and their price target to $250 per share from $300. Analysts also cut price target to $100 per share from $118. Analysts trim price target to $193 per share from $220. BofA raises Merck (MRK) rating to buy from neutral and price target to $130 per share from $110. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ A top 1% performing fund manager explains why history proves the S&P 500 will fall another 30% in the next 3-to-9 months — and shares 11 compelling stocks to buy in 2023 that will power through a rece
▼ + stars: | 2022-12-21 | by ( Lisa Kailai Han | ) www.businessinsider.com time to read: +6 min

He foresees the S&P 500 falling another 30% and bottoming within the next three to nine months. Abate shared 11 compelling stocks to buy to mitigate looming recessionary risks. But with the looming threat of a recession, Abate believes that the days of big contrarian trade ideas are now behind us. Especially "idiosyncratic stocks that have kind of already felt the pain of a downturn, so even if a recession happens, their backlogs can get them through recessionary conditions." Two biotechnology names Abate noted as standout idiosyncratic ideas are Biogen (BIIB) and Gilead (GILD).

☆ Siemens Healthineers, GE Healthcare eye Medtronic units - Bloomberg News
▼ + stars: | 2022-12-15 | by ( ) www.reuters.com time to read: +1 min

Dec 15 (Reuters) - Siemens Healthineers AG (SHLG.DE) and General Electric Co's (GE.N) healthcare business are weighing a potential acquisition of two units being spun off by Medtronic Plc (MDT.N), Bloomberg reported on Thursday, citing people familiar with the matter. Medtronic, the world's largest standalone medical device maker, had announced plans in October to spin off the two units - patient monitoring and respiratory interventions - as it seeks to streamline its portfolio. Bloomberg reported on Thursday that Medtronic was also open to a sale at the right price and the businesses could be valued at more than $7 billion. Medtronic and GE Healthcare did not immediately respond to Reuters request for comment, while Siemens Healthineers declined to comment. Medtronic has been restructuring its business over the last few years in a bid to increase the pace of its revenue growth.

“And the pulse oximeter is used from any age to geriatrics,” he said. The US Food and Drug Administration is mulling over next steps for the regulation of pulse oximeter devices, which may give less accurate readings for people of color. A panel of its Medical Devices Advisory Committee met in November to review clinical data on the issue. “I think of the pulse oximeter reading in the same way. Of course this can be dangerous.”Ultimately, the pulse oximeter can estimate the amount of oxygen a person has in their blood without the need for a blood sample.

☆ What to watch for as J&J gets ready to split into two separate companies next year
▼ + stars: | 2022-12-06 | by ( Paulina Likos | ) www.cnbc.com time to read: +11 min

During Monday's "Morning Meeting" for members, Jim Cramer said that J & J has the "best balance sheet in America." According to projections from J & J and rival Medtronic (MDT), the robotics market captures a low 2% to 3% of global procedures. In an economic slowdown, J & J is a solid name to own that can outperform the broader market. We also like that J & J has consistently raised its dividend. We rate J & J a 1 for the Club , meaning we would buy the stock at current levels given it aligns with our strategy.

Organizations: & $

☆ Bank of America sees a super volatile year ahead but has 2 stock-buy strategies so you can sleep at night
▼ + stars: | 2022-12-06 | by ( Michelle Fox | ) www.cnbc.com time to read: +5 min

"We expect another volatile year and recommend owning High Quality stocks … But today's High Quality stocks look different than a few years ago (e.g. The oil refiner posted third-quarter earnings and revenue that beat Wall Street's expectations in October. The health insurer beat analysts' expectations with its third-quarter earnings report in November. Walmart's strength in its third-quarter earnings came from its food business, which is bigger than Target's. Walmart's per-share earnings beat expectations , while Target reported a third-quarter earnings miss and profit that fell by about 50%.

☆ 31 stocks that mutual funds are heavily betting on, driving their best-performing year since 2007 according to Goldman Sachs
▼ + stars: | 2022-11-25 | by ( Laila Maidan | ) www.businessinsider.com time to read: +3 min

Mutual funds are set to have their best year of outperformance relative to benchmarks since 2007. The report indicates that 56% of large-cap mutual funds outperformed their benchmarks compared to a 36% outperformance rate seen since 2007. Meanwhile, 66% of large-cap value funds outperformed the benchmark Russell 1000 Value index. Below are 31 of the 50 stocks listed in Goldman Sachs' Mutual Fund Overweight Positions basket. The list is based on the investment bank's analysis of 548 large-cap core, growth, and value mutual funds with $2.5 trillion in equity assets.

Dow component (.DJI) Walgreens Boots Alliance Inc (WBA.O) rose 1.9% after Cowen & Co upgraded the drug distributor stock, citing its healthcare services business push. Best Buy Co Inc (BBY.N) soared 9.4%, rising the most among S&P 500 (.SPX) components after forecasting a smaller-than-expected drop in annual sales. Energy (.SPNY) led gains among the 11 major S&P 500 sector indexes, bouncing off four-week lows by adding 2%. Advancing issues outnumbered decliners by a 2.70-to-1 ratio on the NYSE and by a 1.12-to-1 ratio on the Nasdaq. The S&P index recorded 19 new 52-week highs and two new lows, while the Nasdaq recorded 49 new highs and 122 new lows.

Nov 22 (Reuters) - Medtronic Plc (MDT.N) on Tuesday lowered its full-year outlook for profit and revenue growth, blaming a stronger dollar and a slower-than-anticipated recovery in supply chain disruptions, sending the medical device maker's shares down nearly 6%. Medtronic cut its revenue growth expectations for fiscal 2023 to 3.5% to 4%, from 4% to 5%. The company said cost-cutting measures will likely offset lower revenue and inflationary pressures in the second half of the year. A slower-than-anticipated recovery in supply chain disruptions impacted Medtronic's medical surgical business the most, with the unit's revenue falling 10% to $2.07 billion. Reporting by Khushi Mandowara and Bhanvi Satija in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.

SummarySummary Companies Best Buy up, sees smaller annual sales dropMedtronic down, lowers FY profit outlookTesla attempts to recoup losses post slumpFutures up: Dow 0.44%, S&P 0.49%, Nasdaq 0.40%Nov 22 (Reuters) - Wall Street's main indexes were set to open higher on Tuesday, with gains in shares of Walgreens and Best Buy helping investors assuage worries around the economic fallout of stricter COVID-19 curbs in China. Leading gains among S&P 500 (.SPX) components trading before the bell, Best Buy Co Inc (BBY.N) jumped 9.1% after forecasting a smaller-than-expected drop in annual sales ahead of the crucial holiday season. Dow component (.DJI) Walgreens Boots Alliance Inc (WBA.O) rose 1.7% after Cowen & Co upgraded the drug distributor stock, citing its healthcare services business push. ET, Dow e-minis were up 148 points, or 0.44%, S&P 500 e-minis were up 19.25 points, or 0.49%, and Nasdaq 100 e-minis were up 46 points, or 0.4%. Analysts expect thin trading volumes as markets will be shut on Thursday for Thanksgiving holiday and will remain open for half day on Friday.

☆ Stocks making the biggest moves midday: Abercrombie & Fitch, Disney, Best Buy, Zoom and more
▼ + stars: | 2022-11-22 | by ( Alex Harring | ) www.cnbc.com time to read: +5 min

Abercrombie & Fitch – Shares of the retail stock jumped 19% after the apparel retailer beat Wall Street's revenue forecasts for the third quarter and posted unexpected quarterly profit. Deutsche Bank reiterated the stock as buy and said it doesn't see any meaningful changes coming to its direct-to-consumer strategy. Best Buy – Best Buy's stock surged 11% after the consumer electronics retailer beat Wall Street's estimates and maintained its outlook for the holiday period. Demand remains below its pandemic heights, but Best Buy indicated its faring well even as inflation weighs on consumers' pockets. The stock slipped even after the company beat top and bottom line estimates for its latest quarter and better-than-expected comparable store sales.

☆ Stocks making the biggest moves premarket: Best Buy, Dick's Sporting, Abercrombie & Fitch and others
▼ + stars: | 2022-11-22 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines before the bell:Best Buy (BBY) – Best Buy rallied 7% in the premarket after its third-quarter results beat analyst estimates. Dick's Sporting Goods (DKS) – The sporting goods retailer reported better-than-expected third-quarter profit and revenue and an unexpected increase in comparable store sales. Dick's initially surged more than 7% in premarket trading before it dipped negative. Abercrombie & Fitch (ANF) – Abercrombie & Fitch soared 12.8% in premarket action after reporting an unexpected quarterly profit and beating Street revenue forecasts. Dell Technologies (DELL) – Dell fell 1.6% in premarket trading amid a weaker-than-expected current quarter revenue forecast.

☆ Investors have very little to be thankful for in 2022
▼ + stars: | 2022-11-20 | by ( Paul R. La Monica | ) edition.cnn.com time to read: +7 min

Oil stocks have been huge winners this year, thanks to the spike in crude prices…which boosted sales and profits. For now, at least, energy investors are reaping the rewards. And there are also opportunities for investors looking for a little more risk…and potential reward. Finally, investors who’ve bet against the stock market also can give thanks for this year’s volatility. PC giants Dell (DELL) and HP (HPQ) also report results this week.

☆ The week in review, the week ahead — Nov. 18, 2022
▼ + stars: | 2022-11-18 | by ( Zev Fima | ) www.cnbc.com time to read: +5 min

It certainly gave the market some pause in the back half of the week. Looking ahead, we remind members that markets will be closed on Thursday for Thanksgiving, and will close early at 1:00 p.m. Also Thursday, initial jobless claims for the week ending Nov. 12 came in at 222,000, a decrease of 4,000 from the prior week and below expectations of 228,000. Below are some other earnings reports and economic numbers to watch in the week ahead. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ Here are Wednesday's biggest analyst calls: Apple, Nvidia, Tesla, Amazon, Zoom, Walmart & more
▼ + stars: | 2022-11-16 | by ( Michael Bloom | ) www.cnbc.com time to read: +5 min

Here are Wednesday's biggest calls on Wall Street: UBS reiterates Apple as buy UBS said wait times for Apple's iPhone are hitting "extreme levels." Bank of America reiterates Amazon as buy Bank of America said Amazon is a key beneficiary of automation. UBS downgrades Advance Auto Parts to neutral from buy UBS said in its downgrade of Advance Auto Parts that it's losing share. UBS reiterates Walmart as buy UBS said the stocks is undervalued after the company's earnings report on Tuesday. Credit Suisse reiterates Nvidia as outperform After a change in analyst coverage, Credit Suisse named the tech company as a top pick. "

☆ Medtronic CEO Bill George calls on tech founders to hire CEOs
▼ + stars: | 2022-11-14 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMedtronic CEO Bill George calls on tech founders to hire CEOsBill George, Medtronic CEO and author of "True North: Emerging Leader Edition," joins 'Power Lunch' to discuss CEO leadership, tech founders owners under scrutiny and the role of a founder versus that of a CEO.

☆ Cramer's lightning round: I no longer advocate that you should sell Activision Blizzard
▼ + stars: | 2022-11-10 | by ( Krystal Hur | ) www.cnbc.com time to read: 1 min

Loading chart...Advanced Micro Devices Inc : "We've cut the position back for my Charitable Trust. ... We're happy and content to leave the rest and let it run up $8 today." Loading chart...Activision Blizzard Inc : "I actually think that Activision Blizzard on its own right, at this point, could be worth what it's selling for. And therefore, I no longer advocate that you should sell it." Disclaimer: Cramer's Charitable Trust owns shares of AMD.

☆ Stocks making the biggest moves midday: Lyft, Tripadvisor, Take-Two Interactive and more
▼ + stars: | 2022-11-08 | by ( Carmen Reinicke | ) www.cnbc.com time to read: +6 min

Lyft – Shares of Lyft plummeted 21% after the company's earnings report showed mixed results in the last quarter. SolarEdge Technologies – Shares of SolarEdge rose 18% after the company reported record revenue in its last quarter that beat analysts' expectations. Revenue fell short of estimates coming in at $967 million instead of $979 million. Perrigo – Shares of pharmaceutical company Perrigo slumped 16% after the company reported earnings and revenue that fell short of analysts' expectations, according to Refinitiv. The company reported $198.3 million in revenue, which beat expectations, according to StreetAccount.

☆ Stocks making the biggest moves in the premarket: Take-Two Interactive, Lyft, TripAdvisor and more
▼ + stars: | 2022-11-08 | by ( Peter Schacknow | ) www.cnbc.com time to read: +3 min

Lyft (LYFT) – Lyft sank 17.3% in premarket action after its latest quarterly report showed slowing revenue growth and ridership levels that remain below pre-pandemic levels. The ride-hailing service did, however, report better-than-expected earnings for its latest quarter. TripAdvisor (TRIP) – TripAdvisor shares plummeted 20.8% in premarket trading after the travel website operator's quarterly earnings came in below Wall Street forecasts. Coty (COTY) – The cosmetics company reported earnings that matched Wall Street estimates, with revenue slightly above analysts' forecasts. Planet Fitness (PLNT) – The fitness center operator's stock surged 7.1% in the premarket after its quarterly revenue and profit beat Wall Street estimates and it raised its full-year forecast.

Search resuls for: "Medtronic"

25 mentions found